Jakarta, July 5 -- State-owned pharmaceutical firm PT Kimia Farma has introduced Fentakaf, a domestically developed pain relief injection.

The product was launched during the 2025 National Working Meeting (Rakernas) of the Indonesian Association of Anesthesiologists and Intensive Therapy Specialists (PERDATIN) in Jakarta on Friday.

According to the company's statement, the new product is claimed to be a safe and effective anesthetic drug, making it suitable for use by anesthesiologists during surgical procedures.

"This is a strategic move for Kimia Farma to strengthen its position in the anesthesia and intensive therapy product segment," Kimia Farma's Director of Portfolio, Products, and Services, Jasmine K. Karsono, stated.

Fentakaf ...